Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.

Table of Contents

• Continuum of Care: HCV and the Gastroenterologist
• 10 Research, News Highlights Mark GERD Awareness Week
• FDA Designates Recurrent C. difficile Treatment as Breakthrough Therapy
• FDA Grants Priority Review of Daklinza in Difficult-to-Treat Patients
• FDA Updates Labeling for Olysio
• Integration of HCV Care into the Gastroenterology Practice
• Assessing Real-world Outcomes with New HCV Regimens in 2014: HCV-TARGET Registry Findings
• AGA Releases Guideline on EGD Biopsy in Dyspepsia with Normal-appearing Mucosa
• Ablative Therapies Show Promise for Advanced Pancreatic Cancer
• Consumption of Pork Stuffing Leads to Asymptomatic Hepatitis E Outbreak
• Daily Aspirin Increases Chance of Gastrointestinal Cancer Survival
• Debilitating Muscle Cramps Common Among Patients with Cirrhosis
• Differences in IBS Patients’ Microbiota More Significant in Feces vs. Mucosa
• Minimally Invasive Surgical Approaches Inferior to Open Resection for Rectal Cancer
• Nevada Health Officials Investigate Norovirus Outbreak
• Patients with IBD at Increased Risk for Invasive Pneumococcal Disease
• Elevated Aminotransferases Common in US
• Elevated aminotransferases common in US
• Expert Calls for Awareness of Sleep Disorders Among GI Patients
• Researchers Find Possible Link Between Marijuana, HCV
• TOUCHSTONE: Ozanimod Provides Long-term Benefit in Moderate-to-Severe UC
• UNITI-2 Trial: Stelara Effective for Treating Crohn’s Disease
• FDA Issues Warning, AbbVie Explains Label Changes for HCV Drugs
• NIH Awards $1.35 Million for Research on Emulsifiers in Food
• Oral P2X7 Inhibitor Shows Promise in Treating Crohn’s Disease Symptoms
• Second Phase 2 Trial of Microbiome-based Therapeutic for IBS-C Initiated
• Stool Bank Announces Personalized Microbiome Banking for C. difficile